0 Комментарии
0 Поделились
219 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Aβ-Protein Inhibitors Reshaping Alzheimer’s Disease Treatment and Drug DevelopmentThe Changing Alzheimer’s Disease Treatment Landscape Alzheimer’s disease treatment has increasingly shifted from managing symptoms toward disease modification, particularly with therapies designed to target amyloid-beta (Aβ), a protein associated with plaque accumulation in the brain. The development of amyloid beta inhibitors has provided clinical evidence that removing...0 Комментарии 0 Поделились 224 Просмотры 0 предпросмотр
-
Alzheimer's Disease Diagnostic Market - Artificial Intelligence and Biomarker InnovationMarket Overview Artificial intelligence and biomarker innovation represent transformative capabilities advancing Alzheimer's diagnostics through machine learning analysis, novel biomarker identification, and predictive analytics enabling earlier detection and personalized disease assessment. The Alzheimer's Disease Diagnostic Market transformation toward AI sophistication substantially advance...0 Комментарии 0 Поделились 530 Просмотры 0 предпросмотр
-
Alzheimer's Drugs Lead Prescription Drug Demand with 21.7% Market Share in 2025Prescription Drugs Market to Reach USD 2.36 Trillion by 2034, Growing at 7.1% CAGR: Polaris Market Research According to a new report by Polaris Market Research, the global prescription drugs market was valued at USD 1.27 trillion in 2025 and is estimated at USD 1.35 trillion in 2026. It is projected to reach USD 2.36 trillion by 2034, expanding at a CAGR of 7.1% from 2026 to 2034. Growth is...0 Комментарии 0 Поделились 210 Просмотры 0 предпросмотр
-
Alzheimer's Drugs Market Size, Share, Growth Trends and Forecast 2031The growing prevalence of Alzheimer’s disease, combined with a rapidly aging global population, is increasing the demand for effective therapeutic solutions. Advances in disease-modifying treatments, early diagnosis, and neuroscience research are also reshaping treatment approaches. The Alzheimer's Drugs Market is projected to grow from US$ 8.24 billion in 2024 to US$ 26.37 billion by...0 Комментарии 0 Поделились 312 Просмотры 0 предпросмотр
-
Alzheimer's Therapeutics Market: Where Biopharma Leaders Are Investing for the Next DecadeAlzheimer's Therapeutics Market According to the latest report published by Data Bridge Market Research, the Alzheimer's Therapeutics Market Alzheimer’s therapeutics market was valued at USD 5.99 billion in 2024 and is expected to reach USD 11.39 billion by 2032 During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Alzheimer’s Diagnosis and Drugs Market: Key Trends Transforming Dementia CareThe Alzheimer’s Diagnosis and Drugs Market is evolving rapidly as healthcare systems place greater emphasis on early detection, accurate disease identification, and therapies capable of addressing disease progression. Growing investment in neurological research, biomarker-based diagnostics, and innovative treatment approaches is creating new opportunities across the healthcare ecosystem....0 Комментарии 0 Поделились 146 Просмотры 0 предпросмотр
-
Alzheimer’s Disease Diagnostic Market – Early Detection Drives InnovationThe Alzheimer’s disease diagnostic market is expanding as ageing populations, rising dementia prevalence, greater awareness, and advances in biomarkers and imaging increase the need for earlier and more accurate assessment. The market was valued at USD 10.26 billion in 2024 and is projected to reach USD 26.64 billion by 2035, growing at a CAGR of 9.02%. Alzheimer’s disease is the...0 Комментарии 0 Поделились 211 Просмотры 0 предпросмотр
-
Alzheimer’s Therapeutics Market Forecast Highlights Innovation in Alzheimer’s Drug DevelopmentAccording to Future Market Insights (FMI), the global Alzheimer’s therapeutics market is projected to expand from USD 4.3 billion in 2026 to USD 10.4 billion by 2036, registering a 9.2% CAGR during the forecast period. The market was valued at USD 3.9 billion in 2025, creating an incremental opportunity of approximately USD 6.5 billion through 2036. Donepezil is expected to account for...0 Комментарии 0 Поделились 390 Просмотры 0 предпросмотр
-
Could Emerging Therapies Redefine the Alzheimer’s Disease Treatment Market?According to the latest report published by Data Bridge Market Research, the Alzheimer’s Disease Treatment Market CAGR Value The global Alzheimer’s Disease Treatment market size was valued at USD 5.50 billion in 2025 and is expected to reach USD 10.79 billion by 2033, at a CAGR of 8.79% during the forecast period The winning Alzheimer’s Disease Treatment...0 Комментарии 0 Поделились 289 Просмотры 0 предпросмотр
-
Diagnosing Alzheimer's DiseaseAlzheimer's disease is the most common cause of dementia, affecting millions of people worldwide. It is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and changes in behavior. Early and accurate diagnosis is important for several reasons: it allows patients and families to plan, enables access to treatments and support services, and supports research...0 Комментарии 0 Поделились 33 Просмотры 0 предпросмотр
-
How Aging Populations and Biomarker Advances Are Driving the Alzheimer's Disease Diagnostic MarketThe global Alzheimer's disease diagnostic market is expanding as healthcare providers, research institutions, and pharmaceutical companies invest in advanced diagnostic tools to support early detection and disease management. The market was valued at USD 10.26 billion in 2024 and is projected to reach USD 26.64 billion by 2035, growing at a CAGR of 9.02%. The Alzheimer's Disease Diagnostic...0 Комментарии 0 Поделились 185 Просмотры 0 предпросмотр
-
Neurological Biomarkers Market Growth Accelerates with Precision NeurologyThe neurological biomarkers market is entering a transformative phase as healthcare and pharmaceutical research increasingly seek faster, more precise, and less invasive ways to understand neurological disorders. Biomarkers are becoming important not only for diagnosis but also for determining disease progression, evaluating treatment response, supporting patient stratification, and improving...0 Комментарии 0 Поделились 635 Просмотры 0 предпросмотр
-
CNS Biomarkers Market Size, Trends, and Outlook Through 2033The global central nervous system biomarkers market size was valued at USD 5.37 billion in 2024 and is projected to grow USD 5.84 billion in 2025 to USD 11.34 billion by 2033, growing at a CAGR of 8.66% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Central Nervous System Biomarkers Market Growth by...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Complete Home Patient Care Guide: Patient Care Services in Central Delhi and Noida ExtensionHome healthcare has transformed the way families care for their loved ones. Instead of spending long periods in hospitals, patients can now receive compassionate and professional care in the comfort of their own homes. This approach promotes faster recovery, reduces stress, and allows patients to remain close to family members during the healing process. Professional home caregivers provide...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Global Neuroprotective Agents Market Growing at 7.1% CAGR Through 2034According to a new report from Intel Market Research, the global Neuroprotective Agents Market was valued at USD 5.8 billion in 2025 and is projected to grow from USD 6.3 billion in 2026 to USD 10.9 billion by 2034, exhibiting a robust CAGR of 7.1% during the forecast period (2026–2034). This growth is propelled by the escalating burden of neurodegenerative diseases, a rapidly aging...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Patient Care Services in Central Delhi and Defence Colony for Comfortable Home RecoveryRecovering at home can be a comfortable option for patients who need assistance with daily activities but do not require continuous hospital admission. Elderly people, patients returning from the hospital, individuals with limited mobility, and bedridden patients may need regular help with personal care, meals, movement, and companionship. Professional home caregivers can provide this support...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek